1. asheymommy
2. marz11
3. dynamichealthsol
4. franciscaguila78
5. badaleyes
1.dynamichealthsol 02/02/2018
Beats EPS estimates by $0.04.
2.badaleyes 02/02/2018
Big news - Sees FY18 revs $41.2-42.7 bln vs $41.10 bln
3.asheymommy 03/01/2018
4.franciscaguila78 05/04/2018
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
5.dynamichealthsol 01/03/2018
er details
6.marz11 04/10/2018
Merck monotherapy met primary endpoint in phase 3 keynote-042 study, significantly improving OS as first-line…
7.franciscaguila78 06/25/2018
FDA accepts supplemental biologics license application for Merck’s KEYTRUDA
8.marz11 06/25/2018
Presents new data for Sitagliptin Program with JANUVIA
9.dynamichealthsol 02/21/2018
Merck and Viralytics Announce Acquisition Agreement, Expanding Merck's Leading Immuno-Oncology Pipeline
10.dynamichealthsol 04/16/2018
Merck's KEYTRUDA® (pembrolizumab) Plus Pemetrexed (ALIMTA®) and Platinum Chemotherapy Reduced the Risk of Death by Half Compared with Chemotherapy Alone as First-Line Treatment for Advanced Nonsquamou
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW